-
1 Comment
Korian is currently in a long term uptrend where the price is trading 4.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
Korian's total revenue sank by 0.0% to $923M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $32M since the same quarter in the previous year.
Finally, its free cash flow grew by 98.6% to $237M since the same quarter in the previous year.
Based on the above factors, Korian gets an overall score of 3/5.
| Industry | Medical Care Facilities |
|---|---|
| ISIN | FR0010386334 |
| Exchange | PA |
| CurrencyCode | EUR |
| Sector | Healthcare |
| Market Cap | 779M |
|---|---|
| PE Ratio | 29.44 |
| Target Price | 12 |
| Dividend Yield | 3.3% |
| Beta | 1.05 |
Korian provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. As of December 31, 2022, it operated with 87,994 beds. It operates approximately 1,100 care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom. The company was formerly known as Korian-Medica S.A. and changed its name to Korian in July 2015. Korian was founded in 2001 and is based in Paris, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for KORI.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
